WeTrials
Recruiting

Efficacy of Combination Baloxovir and Oseltamivir Therapy in Influenza Infected Immunocompromised Hosts

What is this study?

This study is testing whether using two flu medicines together, baloxavir and oseltamivir, works better than standard treatment for people with weakened immune systems. The goal is to see if this combination can shorten how long you are sick and make the flu infection less severe.

Who can participate?

You may be able to join if you are 12 or older, have the flu, and either have had a blood stem cell transplant or have a blood-related cancer. Participants must be able to swallow pills and not currently need a breathing machine.

What will happen?

During the study, you will be given a combination of antiviral medications to treat your flu infection. Your health team will closely monitor your recovery and check how well the treatment is working against the virus.

Where and when?

This study is currently recruiting participants in Houston, Texas, United States. Talk to your care team to see if this location works for you.

Key Points
  • 1Tests a combination of two flu antiviral medications.
  • 2Designed specifically for patients with weakened immune systems and blood cancers or transplants.
  • 3Currently recruiting patients in Houston, Texas.

Related links

Outside pages about this study, checked by our team

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Hematopoietic and Lymphoid Cell NeoplasmInfluenza

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.